Related Experiment Video

Updated: Jun 5, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes?

Peter R Carroll, Jared M Whitson, Matthew R Cooperberg

    Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
    |December 30, 2010
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    Serum and Plasma Copy Number Detection Using Real-time PCR
    09:21

    Serum and Plasma Copy Number Detection Using Real-time PCR

    Published on: December 15, 2017

    Related Experiment Videos

    Last Updated: Jun 5, 2026

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
    13:19

    Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

    Published on: November 2, 2013

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    Serum and Plasma Copy Number Detection Using Real-time PCR
    09:21

    Serum and Plasma Copy Number Detection Using Real-time PCR

    Published on: December 15, 2017

    Related Concept Videos

    Disorders of the Male Reproductive System01:20

    Disorders of the Male Reproductive System

    Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
    Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
    Sensitivity, Specificity, and Predicted Value01:13

    Sensitivity, Specificity, and Predicted Value

    In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
    Sensitivity is the...

    Articles linked to this work by shared authors, journal, and citation graph.

    A Phase I trial of PLZ4-coated paclitaxel-loaded micelles in patients with refractory non-muscle-invasive bladder cancer.

    Nanomedicine (London, England)·2026

    The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable-risk prostate cancer.

    Cancer·2024

    Amount of Gleason Pattern 3 Is Not Predictive of Risk in Grade Group 2-4 Prostate Cancer.

    European urology·2024

    Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2024

    Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer.

    BJUI compass·2024

    Prostate cancer risk stratification using magnetic resonance imaging-ultrasound fusion vs systematic prostate biopsy.

    JNCI cancer spectrum·2023

    Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell Lymphoma.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Risk-Adapted Optimization of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2-Positive Early-Stage Breast Cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

    Purple Blossoms.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us